Pfizer-BioNTech’s new bivalent Covid-19 vaccine—which targets the original strain and some Omicron subvariants—provides more protection against the virus and its omicron variants than its initial vaccine, according to a study released Friday.
Subscribe to:
Post Comments (Atom)
< + > Are You Experiencing Data Chaos or Clean Identity with Your EMPI?
Identity management is one of the most challenging problems healthcare IT organizations face. For those not familiar with identity manageme...
No comments:
Post a Comment